General
Preferred name
OSI-413
Synonyms
P&D ID
PD082111
CAS
183321-86-0
183320-51-6
183365-34-6
Tags
probe
Probe info
Probe type
calculated probe
Probe sources
Probe targets
[[ compound.targets[t].gene_name ]]
Probe control
Probe control available, exact structure not defined
Orthogonal probes
78
No orthogonal probes found
Similar probes
33
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
OSI-413 is an impurity of Erlotinib, a selective epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
0
Compound Sets
2
BOC Sciences Bioactive Compounds
Probe Miner (suitable probes)
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
15
Properties
(calculated by RDKit )
Molecular Weight
379.15
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
2
Rotatable Bonds
9
Ring Count
3
Aromatic Ring Count
3
cLogP
2.75
TPSA
85.73
Fraction CSP3
0.24
Chiral centers
0.0
Largest ring
6.0
QED
0.44
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Source data